ArticleDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2020

Chitosan-Raloxifene nanoparticle containing doxorubicin as a new double-effect targeting vehicle for breast cancer therapy.

Zohreh Mohammadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.